BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 30.85
-0.65 (-2.06%)
Oct 20, 2026, 1:30 PM CST
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 3.97M TWD in the quarter ending June 30, 2026, with 151.71% growth. This brings the company's total for the last twelve months to 10.60M, up 427.82% year-over-year. In the year 2025, BRIM Biotechnology had annual revenue of 5.49M with 1,548.65% growth. That makes BRIM Biotechnology the 44,998th largest company in the world by revenue and 2,183rd in Taiwan.
Revenue (ttm)
10.60M
Revenue Growth
+427.82%
P/S Ratio
387.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.10B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full BRIM Biotechnology breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.49M | 5.16M | 1,548.65% |
| Dec 31, 2024 | 333.00K | 243.00K | 270.00% |
| Dec 31, 2023 | 90.00K | -436.00K | -82.89% |
| Dec 31, 2022 | 526.00K | 166.00K | 46.11% |
| Dec 31, 2021 | 360.00K | -90.41M | -99.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SYN-TECH Chem. & Pharm. | 1.27B |
| Medigen Biotechnology | 1.27B |
| Mycenax Biotech | 815.87M |
| BioGend Therapeutics | 236.58M |
| Pharmosa Biopharm | 53.38M |
| Formosa Pharmaceuticals | 52.59M |
| Shine-On BioMedical | 50.62M |
| UnicoCell Biomed | 22.46M |